PAPER
Bi(OTf)3 as Novel and Efficient Catalyst
2525
3-(4,6-Di-O-benzyl-2,3-dideoxy-a-D-erythro-hex-2-enopyrano-
syl)-1-propene (3e)
J = 2.4, 10.0 Hz, 1 H), 5.80 (ddt, J = 6.8, 10.3, 17.3 Hz, 1 H), 5.95
(dd, J = 2.5, 10.3 Hz, 1 H), 6.03 (dd, J = 2.4, 10.3 Hz, 1 H).
13C NMR (1H-decoupled, CDCl3): d = 20.7, 20.8, 36.8, 62.8, 63.7,
68.0, 72.1, 117.5, 122.0, 133.8, 134.7, 170.3, 170.5.
Liquid; [a]D25 +40.1 (c = 1.5, CHCl3).
1H NMR (CDCl3): d = 2.25 (ddd, J = 5.7, 8.5, 14.3 Hz, 1 H), 2.45
(ddd, J = 6.0, 7.5, 14.3 Hz, 1 H), 3.65 (dq, J = 4.0, 12.0 Hz, 2 H),
3.78 (ddd, J = 3.5, 6.5, 9.8 Hz, 1 H), 3.97 (dd, J = 3.5, 12.0 Hz, 1
H), 4.20 (dt, J = 2.0, 6.0, 8.5 Hz, 1 H), 4.50 (dd, J = 8.5, 14.7 Hz, 2
H), 4.58 (dd, J = 6.5, 14.7 Hz, 2 H), 5.05 (dd, J = 1.3, 17.3 Hz, 1 H),
5.10 (dd, J = 1.5, 17.3 Hz, 1 H), 5.79 (ddt, J = 7.3, 10.3, 17.2 Hz, 1
H), 5.83 (dt, J = 2.0, 2.4, 10.3 Hz, 1 H), 5.85 (dt, J = 1.2, 2.0, 10.3
Hz, 1 H), 7.23–7.35 (m, 10 H).
Anal. Calcd for C13H18O5 (254.28): C, 61.41; H, 7.13. Found: C,
61.05; H, 7.65.
4,6-Di-O-acetyl-2,3-dideoxy-a-D-threo-hex-2-enopyranosyl Cy-
anide (3j)
Solid; mp 115 °C [a]D25 –353 (c = 1.0, CHCl3).
IR (neat): 2927, 2359, 1746, 1436, 1372, 1228, 1048, 1010, 915,
765 cm–1.
1H NMR (CDCl3): d = 2.08 (s, 6 H), 4.19 (dt, J = 4.0, 9.0 Hz, 1 H),
4.25 (dd, J = 4.0, 11.8 Hz, 2 H), 5.15 (dd, J = 2.5, 9.0 Hz, 2 H), 6.05
(dd, J = 3.5, 10.3 Hz, 1 H), 6.25 (dd, J = 2.5, 10.3 Hz, 1 H).
13C NMR (1H-decoupled, CDCl3; a-isomer): d = 20.5, 20.6, 62.0,
62.4, 63.5, 71.8, 115.5, 123.4, 129.4, 169.8, 169.9.
13C NMR (1H-decoupled, CDCl3): d = 38.0, 69.3, 69.9, 70.7, 71.4,
71.9, 73.2, 96.1, 117.1, 125.7, 127.3, 127.4, 127.5, 127.7, 128.1,
128.2, 130.9, 134.4, 138.2.
3-(4,6-Di-O-pivolyl-2,3-dideoxy-a-D-erythro-hex-2-enopyrano-
syl)-1-propene (3f)
Liquid; [a]D25 +82.2 (c = 1.0, CHCl3).
1H NMR (CDCl3): d = 1.20 (s, 18 H), 2.30 (ddd, J = 5.5, 8.7, 14.2
Hz, 1 H), 2.45 (ddd, J = 6.0, 7.9 14.2 Hz, 1 H), 3.97 (ddd, J = 3.3,
6.5, 9.8 Hz, 1 H), 4.18 (dd, J = 3.3, 12.0 Hz, 2 H), 4.28 (dd, J = 6.2,
12.0 Hz, 1 H), 5.07 (ddd, J = 2.4, 5.5, 8.7 Hz, 1 H), 5.10 (dd, J = 1.3,
17.2 Hz, 1 H), 5.13 (dd, J = 1.5, 17.2 Hz, 1 H), 5.78 (dt, J = 2.4, 10.5
Hz, 1 H), 5.85 (ddt, J = 7.0, 10.3, 17.2 Hz, 1 H), 5.91 (dt, J = 2.3,
10.5 Hz, 1 H).
13C NMR (1H-decoupled, CDCl3; b-isomer): d = 20.5, 20.6, 62.3,
62.7, 63.3, 74.2, 115.3, 124.0, 128.5, 169.8, 169.9.
Anal. Calcd for C11H13NO5 (239.23): C, 55.23; H, 5.48, N, 5.86.
Found: C, 55.61; H, 5.50, N, 5.37.
Acknowledgements
13C NMR (1H-decoupled, CDCl3): d = 27.0, 27.1, 38.0, 38.7, 38.8,
62.9, 64.7, 70.4, 71.2, 117.3, 123.9, 132.7, 134.1, 177.8, 178.1.
BVS, KSR, LC and VS thank CSIR, New Delhi for the award of fel-
lowships.
4,6-Di-O-pivolyl-2,3-dideoxy-a-D-erythro-hex-2-enopyranosyl
Cyanide (3g)
References
Liquid; [a]D25 +36.8 (c = 1.45, CHCl3).
(1) (a) Lewis, M. D.; Cha, J. K.; Kishi, Y. J. Am. Chem. Soc.
1982, 104, 4976. (b) Paterson, L.; Keown, L. E.
Tetrahedron Lett. 1997, 38, 5727. (c) Horita, K.; Sakkurai,
Y.; Nagasawa, M.; Hacliya, S.; Yonemistu, O. Synlett 1994,
43.
(2) (a) Weatherman, R. V.; Mortell, K. H.; Chervenak, M.;
Kiessling, L. L.; Toone, E. J. Biochem. 1996, 35, 3619.
(b) Levy, D. E.; Tan, C. The Chemistry of C-Glycosides;
Pergamon Press: Oxford, 1995.
IR (neat): 2950, 1755, 1748, 1652, 1438, 1370, 1225, 1108, 1040,
1010, 980, 920 cm–1.
1H NMR (CDCl3): d = 1.25 (s, 18 H), 4.05 (dt, J = 3.8, 9.0 Hz, 1 H),
4.25 (dd, J = 12.0 Hz, 2 H), 5.10 (dt, J = 3.5, 2.5 Hz, 1 H), 5.35 (dq,
J = 2.5, 9.0 Hz, 1 H), 5.90 (dt, J = 3.5, 10.5 Hz, 1 H), 6.05 (dt, J =
2.5, 10.5 Hz, 1 H).
13C NMR (1H-decoupled, CDCl3): d = 27.0, 27.2, 38.0, 38.6, 63.5,
64.0, 72.3, 74.6, 115.8, 123.9, 124.0, 177.8, 178.1.
(3) (a) Du, Y.; Linhardt, R. J. Tetrahedron 1998, 54, 9913.
(b) Nicolaou, K. C.; Duggan, M. E.; Hwang, C. K.; Somers,
P. K. J. Chem. Soc., Chem. Commun. 1985, 1359.
(c) Wincott, F. E.; Danishefsky, S. J.; Schutte, G.
Tetrahedron Lett. 1987, 28, 4951. (d) Andersen, L.;
Mikkelsen, L. M.; Beau, J. M.; Skrydstrup, T. Synlett 1998,
1393. (e) Mazeas, D.; Skrydstrup, T.; Beau, J. M. Angew.
Chem., Int. Ed. Engl. 1995, 909.
(4) (a) Suhadolnik, R. J. Nucleoside Antibiotics; Wiley-
Interscience: New York, 1970. (b) Hanessian, S. C. Total
Synthesis of Natural Products: The Chiron Approach;
Pergamon Press: Oxford, 1984.
(5) (a) Danishefsky, S. J.; Keerwin, J. F. J. Org. Chem. 1982, 47,
3803. (b) De Raadt, A.; Griegl, H.; Klempic, N.; Stutz, A. E.
J. Org. Chem. 1993, 58, 3179. (c) De LasHeras, F. G.;
Felix, A. S.; Ferdanzandez-Risa, P. Tetrahedron 1983, 39,
1617. (d) Kunz, H.; Weibmuller, J.; Muller, B. Tetrahedron
Lett. 1984, 25, 3571.
(6) (a) Dawe, R. D.; Fraser-Reid, B. J. Chem. Soc., Chem.
Commun. 1981, 1180. (b) Toshima, K.; Ishizuka, T.;
Matsuo, G.; Nakata, M. Chem. Lett. 1993, 2013.
(c) Toshima, K.; Miyamito, N.; Matsuo, G.; Nakata, M.;
Matsumura, S. Chem. Commun. 1996, 1379.
3-(4,6-Di-O-methyl-2,3-dideoxy-a-D-erythro-hex-2-enopyrano-
syl)-1-propene (3h)
Liquid; [a]D25 +34.5 (c = 3.0, CHCl3).
1H NMR (CDCl3): d = 2.25 (ddd, J = 5.7, 8.5, 14.3 Hz, 1 H), 2.45
(ddd, J = 6.0, 7.5, 14.3 Hz, 1 H), 3.40 (s, 6 H), 3.53–3.65 (m, 4 H),
4.20 (dt, J = 2.0, 6.0, 8.3 Hz, 1 H), 5.05 (dd, J = 1.5, 17.3 Hz, 1 H),
5.10 (dd, J = 1.5, 17.3 Hz, 1 H), 5.79–5.98 (m, 3 H).
13C NMR (1H-decoupled, CDCl3): d = 37.9, 56.0, 58.9, 70.7, 71.4,
71.7, 72.0, 124.8, 125.4, 130.9, 133.6.
Anal. Calcd for C11H18O3 (198.26): C, 66.64; H, 9.15. Found: C,
66.05; H, 9.87.
3-(4,6-Di-O-acetyl-2,3-dideoxy-a-D-threo-hex-2-enopyranosyl)-
1-propene (3i)
Liquid; [a]D25 –293 (c = 1.0, CHCl3).
1H NMR (CDCl3): d = 2.07 (s, 3 H), 2.15 (s, 3 H), 2.24 (ddd, J = 5.6,
8.5, 14.3 Hz, 1 H), 2.43 (ddd, J = 6.3, 7.7, 14.5 Hz, 1 H), 4.09 (ddd,
J = 3.5, 6.3, 10.3 Hz, 1 H), 4.18 (dd, J = 3.5, 12.0 Hz, 1 H), 4.20 (dd,
J = 6.3, 12.0 Hz, 1 H), 4.33 (ddd, J = 2.5, 5.0, 8.5 Hz, 1 H), 5.03 (dd,
J = 1.7, 17.3 Hz, 1 H), 5.10 (dd, J = 1.8, 17.3 Hz, 1 H), 5.15 (dd,
Synthesis 2004, No. 15, 2523–2526 © Thieme Stuttgart · New York